Приказ основних података о документу

dc.creatorPopović, Gordana
dc.creatorPfendt, Lidija
dc.date.accessioned2019-09-02T10:49:35Z
dc.date.available2019-09-02T10:49:35Z
dc.date.issued1996
dc.identifier.issn0365-4877
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/144
dc.description.abstractTwo spectrophotometric methods are proposed for the determination of flurazepam in pharmaceutical formulations. The first one, a very sensitive and fast direct spectrophotometric method is based on the measurement of the absorbance of aqueous flurazepam monohydrochloride solution (pH 6) at the wavelength of maximum absorption at 230 nm. The second one, a difference spectrophotometric method, is based on the measurement of the absorbance difference between equimolar solutions of flurazepam monoprotonated (pH 6) and diprotonated (pH 0) forms at 225 nm. Both methods were applied to the determination of flurazepam in capsules which contain flurazepam monohydrochloride. To extend the application range of both methods, we examined optimum conditions which enable the determination of flurazepam in formulations in form of flurazepam dihydrochloride.en
dc.publisherEditions Scientifiques Elsevier, Paris Cedex 15
dc.rightsrestrictedAccess
dc.sourceAnalusis
dc.subjectDifference spectrophotometryen
dc.subjectFlurazepamen
dc.subjectFlurazepam formulationsen
dc.subjectSpectrophotometric determinationen
dc.titleSpectrophotometric determination of flurazepam in pharmaceutical formulationsen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractПоповић, Гордана; Пфендт, Лидија;
dc.citation.volume24
dc.citation.issue6
dc.citation.spage259
dc.citation.epage262
dc.citation.other24(6): 259-262
dc.identifier.wosA1996VL57800019
dc.identifier.scopus2-s2.0-0344601434
dc.identifier.rcubhttps://hdl.handle.net/21.15107/rcub_farfar_144
dc.type.versionpublishedVersion


Документи

ДатотекеВеличинаФорматПреглед

Уз овај запис нема датотека.

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу